Analytical Data
-
基因名
ScFv16
- Application
-
别名
Ig kappa chain V-II region 7S34.1; Mus musculus; Mouse; Monoclonal antibody
-
种属
Mouse
-
表达系统
Baculovirus
-
标签
Tag Free
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P01630
-
表达区间
D1-R113
-
蛋白长度
Full Length
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HKR3 recombinant protein, a significant focus in immunological research, is derived from the human kidney-derived protein HKR3, which has been implicated in various cellular processes, including immune response regulation and kidney function. Recent studies have highlighted its potential role in modulating inflammation and tissue repair, positioning it as a candidate for therapeutic applications in autoimmune diseases and kidney disorders. The expression and characterization of HKR3 recombinant protein allow researchers to investigate its biological functions and interactions at a molecular level. This investigation is critical for understanding the underlying mechanisms of diseases and for developing targeted treatments. Advances in recombinant DNA technology have facilitated the production of this protein in various systems, enabling large-scale purification and detailed functional analyses. Furthermore, the exploration of HKR3's interactions with other cellular molecules offers insights into the inflammatory pathways and regulatory networks involved in both health and disease. Overall, the study of HKR3 recombinant protein is poised to contribute to novel therapeutic strategies and enhance our knowledge of renal and immune system dynamics.
